Issue

Vol. 26 No. 2 (2014): Vol 26 Issue 2

Copyright (c) 2014 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Subduing the Hepatotoxic and Urotoxic Effects of Cyclophosphamide using Natural Antioxidants

https://doi.org/10.14233/ajchem.2014.15762
Sudarshan S. Iyer
School of Chemical and Biotechnology, SASTRA University, Thanjavur-613401, India *Corresponding author: Tel: +91 4362 264101-8; Extn: 2257/3667; E-mail: ssenthilkumar@biotech.sastra.edu
Sabyasachi Mishra
School of Chemical and Biotechnology, SASTRA University, Thanjavur-613401, India *Corresponding author: Tel: +91 4362 264101-8; Extn: 2257/3667; E-mail: ssenthilkumar@biotech.sastra.edu
Khushboo Ohdar
School of Chemical and Biotechnology, SASTRA University, Thanjavur-613401, India *Corresponding author: Tel: +91 4362 264101-8; Extn: 2257/3667; E-mail: ssenthilkumar@biotech.sastra.edu
Senthilkumar Subramanian*
School of Chemical and Biotechnology, SASTRA University, Thanjavur-613401, India *Corresponding author: Tel: +91 4362 264101-8; Extn: 2257/3667; E-mail: ssenthilkumar@biotech.sastra.edu

Asian Journal of Chemistry, Vol. 26 No. 2 (2014): Vol 26 Issue 2

Abstract

Cyclophosphamide is a commercially popular chemotherapeutic drug and is used in the treatment of malignant and non-malignant forms of cancer. Action of hepatic microsomal enzymes on cyclophosphamide metabolizes it into phosphoramide mustard and acrolein. These are toxic and are majorly found to have adverse effects on the kidney and liver causing symptoms like dypsia, fibrosis, hemorrhagic cystitis and necropsis. Acrolein-one of the metabolites was found to interact with majority of biomolecules like DNA, RNA and proteins that may lead to cellular apoptosis. Cyclophosphamide metabolism was also known to induce the production of reactive oxygen species leading to total cellular damage, which causes various acute and chronic diseases. Herbal plants are found to be rich in antioxidant and have anticancerous and tumor reducing properties. Present study aimed in achieving modulatory action of the poly-herbal combination BC and vitamin E on cyclophosphamide induced hepato- and uro-toxicity. Wistar rats (male and female) were treated orally with the 100 mg/kg of the BC and 50 mg/kg of Vit-E for whole of the study (30 days). 200 mg/kg of cyclophosphamide was administered in 2 split doses through i.p. on day 20 and 21. Serum was used to analyze the clinical chemistry parameters such as total protein, albumin, bilirubin (total and direct), urea, creatinine and enzymes like AST and ALT. Parameters that were significantly altered due to cyclophosphamide administration were modulated during treatment using BC + Vit-E (BCE). By these preliminary studies, it has been hypothesized that the effects of cyclophosphamide were treated to a great extent and therapeutic effect of cyclophosphamide has been sensitized by BCE.

Keywords

Hepatotoxic Urotoxic Cyclophosphamide Antioxidants.
S. Iyer, S., Mishra, S., Ohdar, K., & Subramanian*, S. (2014). Subduing the Hepatotoxic and Urotoxic Effects of Cyclophosphamide using Natural Antioxidants. Asian Journal of Chemistry, 26(2), 544–548. https://doi.org/10.14233/ajchem.2014.15762
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. H.T. Mouridsen and E. Jacobsen, Acta Pharmacol. Toxicol., 36, 409 (1975); doi:10.1111/j.1600-0773.1975.tb00808.x.
  2. R.A. Fleming, Pharmacotherapy: J. Human Pharmacol. Drug Ther., 17, 146 (1997).
  3. M. Colvin, R.B. Brundrett, M.N.N. Kan, I. Jardine and C. Fenselau, Cancer Res., 36, 1121 (1976).
  4. http://www.drugs.com/cons/cyclophosphamide-oral-intravenous.html.
  5. F.S. Philips, S.S. Sternberg, A.P. Cronin and P.M. Vidal, Cancer Res., 21, 1577, (1961).
  6. T.J. Stillwell and R.C. Benson, Cancer, 61, 451 (1988); doi:10.1002/1097-0142(19880201)61:3<451::AID-CNCR2820610308>3.0.CO;2-G.
  7. K.F. Fairley, J. Barrie and W. Johnson, Lancet, 299, 568 (1972); doi:10.1016/S0140-6736(72)90358-3.
  8. D. Schmahl and M. Habs, Int. J. Cancer, 23, 706 (1979); doi:10.1002/ijc.2910230518.
  9. K. Tremellen, Hum. Reprod. Update, 14, 243 (2008); doi:10.1093/humupd/dmn004.
  10. R.O. Beauchamp, D.A. Andjelkovich, A.D. Kligerman, K.T. Morgan, H.D.A. Heck and V.J. Feron, CRC Crit. Rev. Toxicol., 14, 309 (1985); doi:10.3109/10408448509037461.
  11. M. Sulkowska, S. Sulkowski, E. Skrzydlewska and R. Farbiszewski, Exp. Toxicol. Pathol., 50, 209 (1998); doi:10.1016/S0940-2993(98)80085-7.
  12. P.K. Vayalil, G. Kuttan and R. Kuttan, J. Altern. Complement. Med., 8, 787 (2002); doi:10.1089/10755530260511801.
  13. R. Govindarajan, M. Vijayakumar and P. Pushpangadan, J. Ethnopharmacol., 99, 165 (2005); doi:10.1016/j.jep.2005.02.035.
  14. K. Sheeja and G. Kuttan, Integr. Cancer Ther., 5, 244 (2006); doi:10.1177/1534735406291984.
  15. K.B.H. Kumar and R. Kuttan, Phytomedicine, 12, 494 (2005); doi:10.1016/j.phymed.2004.03.009.
  16. G.W. Burton and M.G. Traber, Annu. Rev. Nutr., 10, 357 (1990); doi:10.1146/annurev.nu.10.070190.002041.
  17. H.S. Puri, Rasayana: Ayurvedic Herbs for Longevity and Rejuvenation (Traditional Herbal Medicines for Modern Times), CRC (Vol. 2) (2002)
  18. M. Thakur, N.S. Chauhan, S. Bhargava and V.K. Dixit, Arch. Sex. Behav., 38, 1009 (2009); doi:10.1007/s10508-008-9444-8.
  19. E.A. Abdel-Magied, H.A. Abdel-Rahman and F.M. Harraz, J. Ethnopharmacol., 75, 1 (2001); doi:10.1016/S0378-8741(00)00348-2.
  20. K.N. Prasad, A. Kumar, V. Kochupillai and W.C. Cole, J. Am. Coll. Nutr., 18, 13 (1999); doi:10.1080/07315724.1999.10718822.
  21. C.K. Chow, Free Radic. Biol. Med., 11, 215 (1991); doi:10.1016/0891-5849(91)90174-2.
  22. S.K. Bjelogrlic, J. Radic, V. Jovic and S. Radulovic, Basic Clin. Pharmacol. Toxicol., 97, 311 (2005); doi:10.1111/j.1742-7843.2005.pto_166.x.
  23. S.A. Majumdar, N.M. Saraf and R.Y. Kamble, Iran. J. Pharmacol. Ther., 9, 103, (2010).
  24. R. Zafar, and B.P.S. Sagar, Pharmaceutical Biology, 38, 357, (2000).
  25. S.K. Bhattacharya, K.S. Satyan and S. Ghosal, Indian J. Exp. Biol., 35, 236 (1997).
  26. L. Davis and G. Kuttan, J. Ethnopharmacol., 71, 193 (2000); doi:10.1016/S0378-8741(99)00206-8.
  27. N. Singh, R. Nath, A. Lata, S.P. Singh, R.P. Kohli and K.P. Bhargava, Pharm. Biol., 20, 29 (1982); doi:10.3109/13880208209083282.
  28. T. Jeyanthi and P. Subramanian, Ren. Fail., 31, 814 (2009); doi:10.3109/08860220903150320.
  29. P. Bhatia, S.I.S. Rattan, J. Cavallius and B.F. Clark, Med. Sci. Res., 15, 515 (1987).
  30. P.S.M. Prince and V.P. Menon, J. Ethnopharmacol., 65, 277 (1999); doi:10.1016/S0378-8741(98)00164-0.
  31. B. Bishayi, S. Roychowdhury, S. Ghosh and M. Sengupta, J. Toxicol. Sci., 27, 139 (2002); doi:10.2131/jts.27.139.
  32. T.P. Hamsa and G. Kuttan, Exp. Toxicol. Pathol., 64, 307 (2012); doi:10.1016/j.etp.2010.09.003.
  33. X. Bai, W. Zhang, W. Chen, W. Zong, Z. Guo and X. Liu, Afr. J. Biotechnol., 10, 267 (2011).
  34. I. Gulcin, Int. J. Food Sci. Nutr., 56, 491 (2005); doi:10.1080/09637480500450248.
  35. A.F. Majdalawieh and R.L. Carr, J. Med. Food, 13, 371 (2010); doi:10.1089/jmf.2009.1131.
  36. H.Y. Cheng, T.C. Lin, K.H. Yu, C.M. Yang and C.C. Lin, Biol. Pharm. Bull., 26, 1331 (2003); doi:10.1248/bpb.26.1331.
  37. S.A. Tasduq, K. Singh, N.K. Satti, D.K. Gupta, A.K. Suri and R.K. Johri, Hum. Exp. Toxicol., 25, 111 (2006); doi:10.1191/0960327106ht601oa.
  38. B. Hazra, R. Sarkar, S. Biswas and N. Mandal, BMC Complement. Altern. Med., 10, 20 (2010); doi:10.1186/1472-6882-10-20.
  39. M.C. Sabu and R. Kuttan, Indian J. Exp. Biol., 47, 270 (2009).
  40. T.P. Rao, N. Sakaguchi, L.R. Juneja, E. Wada and T. Yokozawa, J. Med. Food, 8, 362 (2005); doi:10.1089/jmf.2005.8.362.
  41. J.K. Jose and R. Kuttan, J. Ethnopharmacol., 72, 135 (2000); doi:10.1016/S0378-8741(00)00219-1.
  42. N.P. Trivedi and U.M. Rawal, Indian J. Exp. Biol., 39, 41 (2001).
  43. R. Ajaya Kumar, K. Sridevi, N. Vijaya Kumar, S. Nanduri and S. Rajagopal, J. Ethnopharmacol., 92, 291 (2004); doi:10.1016/j.jep.2004.03.004.
  44. Y.Y. Lim and J. Murtijaya, LWT-Food Science and Technology, 40, 1664 (2007); doi:10.1016/j.lwt.2006.12.013.
  45. F. Naaz, S. Javed and M.Z. Abdin, J. Ethnopharmacol., 113, 503 (2007); doi:10.1016/j.jep.2007.07.017.
  46. A.K. Kiemer, T. Hartung, C. Huber and A.M. Vollmar, J. Hepatol., 38, 289 (2003); doi:10.1016/S0168-8278(02)00417-8.
  47. S. Senthilkumar, S.K. Yogeeta, R. Subashini and T. Devaki, Chem. Biol. Interact., 160, 252 (2006); doi:10.1016/j.cbi.2006.02.004.
  48. M.I. Gharib and A.K. Burnett, Eur. J. Heart Fail., 4, 235 (2002); doi:10.1016/S1388-9842(01)00201-X.
  49. Y. Mano, H. Tsukada, T. Kurihara, M. Nomura, K. Yokogawa and K. Miyamoto, Biol. Pharm. Bull., 29, 1692 (2006); doi:10.1248/bpb.29.1692.
  50. S.T. McMurry, R.L. Lochmiller, M.R. Vestey and C.W. Qualls Jr., Arch. Environ. Contam. Toxicol., 27, 14 (1994); doi:10.1007/BF00203881.
  51. D. Ennulat, D. Walker, F. Clemo, M. Magid-Slav, D. Ledieu, M. Graham, S. Botts and L. Boone, Toxicol. Pathol., 38, 810 (2010); doi:10.1177/0192623310374332.
  52. J.J. Lemasters, G.J. Gores, A.L. Nieminen, T.L. Dawson, B.E. Wray and B. Herman, Environ. Health Perspect., 84, 83 (1990).
  53. S. Senthilkumar, T. Devaki, B.M. Manohar and M.S. Babu, Clin. Chim. Acta, 364, 335 (2006); doi:10.1016/j.cca.2005.07.032.
  54. D.J. Meyer and J.W. Harvey, Veterinary Laboratory Medicine, Interpretation Diagnosis, Saunders, Philadelphia, PA, p. 174 (2004).
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 0 Download : 0